Dutch National Prospective EMR Cohort

Overview

A Prospective Study: Longterm Follow Up until S2 (2nd surveillance) at 18 months after EMR for Large Flat/Sessile Colonic Polyps.

Full Title of Study: “Dutch National Prospective EMR Cohort. Longterm Follow Up After EMR for Large Flat/Sessile Colonic Polyps, a Prospective Study.”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 2022

Clinical Trial Outcome Measures

Primary Measures

  • Complications
    • Time Frame: 30 days post EMR
    • Delayed bleeding, perforation and postpolypectomy syndrome
  • Recurrence
    • Time Frame: 6 months (S1) and 18 months (S2) after EMR
    • Pathological and endoscopical re-appearance of adenoma

Participating in This Clinical Trial

Inclusion Criteria

  • Flat or sessile polyp morphology (Paris classification 0-IIa/b/c, Is) – Polyp size >20 mm – Therapy: EMR – Age > 18 years old – Written informed consent Exclusion Criteria:

  • Participation in a competing study, such as the "CLIPPER trial" (registration number: NL62949.091.17).

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Radboud University Medical Center
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • E. Van Geenen, dr, Principal Investigator, Radboud University Medical Center
  • Overall Contact(s)
    • Ayla Turan, MSc, +31(0)611368110, ayla.turan@radboudumc.nl

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.